Data from the POLARGO trial potentially establishes a new standard of care for patients with R/R DLBCL ineligible for ...

The guidelines include disease-specific recommendations screening, monitoring disease progression, and treatment options for ILD.

When to use apremilast and biologics and how to deal with vascular involvement were some of the main areas to be updated in ...